Intellect Design Arena (INTELLECT) near Rs 505: Is the 16% share-price crash justified when AI revenue is growing but profits are not?
Read More Pharma Industry News AstraZeneca to acquire Icosavax in $1.1bn deal to boost vaccine development In a definitive move, AstraZeneca has entered into an agreement to acquire Icosavax, Inc., a U.S.-based biopharmaceutical company… byPallavi MadhirajuDecember 13, 2023